dihexa safety side effects & Risks Dihexa: Mechanism, Effects & Research
Description
An epidemiological and etiological analysis of 5026 peripheral nerve lesions from a european level I trauma center
Non-selective c-Met inhibitors include crizotinib (PF-02341066), foretinib (XL-880), cabozantinib (XL-184), glesatinib (MGCD265), BMS-777607, and MK2461, which in addition to c-Met, can inhibit other tyrosine kinases, such as ALK, RON, VEGFR2, KIT, TIE2, PDGFR, VEGFR1, VEGFR3, RET, and FLT-3 [163,164,165], through binding to the ATP binding site on tyrosine kinases
Its safety and effectiveness for human use have not been confirmed through comprehensive clinical trials
Mezagitamab induces immunomodulatory effect in patients with relapsed/refractory multiple myeloma (RRMM)
